Roundtable

[RT3] Real-World Insights into Payers’ Strategies with the 340B Drug Discount Program

ACPE UAN: 0233-0000-19-046-L04-P | Contact Hours: 0.5 | Activity Type: Knowledge-based

Faculty(s)

• 

  Linda R. Bolland, PharmD, MBA

  Senior Advisor
  Precision for Value
  Gladstone, New Jersey
• 

  Dominic Galante, MD, MS

  Chief Medical Officer
  Precision for Value
  Gladstone, New Jersey

Please note, space is limited to approximately 30 participants on a first come, first served basis. This learning activity will be offered twice: 4:30 pm to 4:55 pm (round 1) and 5:05 pm to 5:30 pm (round 2).
This roundtable will feature two subject matter experts to help facilitate a discussion amongst attendees on strategies and lessons learned in addressing challenges faced by payers as a result of 340B programs. Attendees will share their experiences with each other to help inform this peer-to-peer information exchange.

How can you prepare for this roundtable?
• Attend the prerequisite session titled, [L5] Evolving 340B Program and its Impact on the Payer and Health Systems Landscape.
• Download and review all handout material prior to participating in this roundtable.

Recommended audience: Managed care professionals working in health plans interested in discussing strategies to address payer challenges due to 340B programs.

Learning Objectives:

At the completion of this activity, participants should be able to:

1. Discuss real-world payer strategies in managing challenges resulting from the 340B drug discount program.